WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in GALT — Galectin Therapeutics Inc

CIK 1632972 PLYMOUTH, MN

Position in GALT

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$76,801

+$30,647 QoQ

Shares Held

16,552

+0.1% QoQ

Ownership

0.025%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 7 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $166,117,226 across 147 Biotechnology names. GALT ranks #117 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	45,889	$22,794,442
2	REGN	Regeneron Pharmaceuticals, Inc.	33,880	$21,125,535
3	INCY	Incyte Corp	151,505	$17,174,606
4	EXEL	Exelixis, Inc.	207,728	$11,302,480
5	RPRX	Royalty Pharma plc	179,888	$10,086,320
6	CORT	Corcept Therapeutics Inc	76,278	$6,632,372
7	HALO	Halozyme Therapeutics, Inc.	70,797	$5,541,281
8	AXSM	Axsome Therapeutics, Inc.	19,919	$4,875,573

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$76,801	16,552	+0.1%	Shares	Sole	2026-07-15
2026-03-31	$46,154	16,543	-53.0%	Shares	Sole	2026-04-08
2025-12-31	$146,502	35,217	-0.1%	Shares	Sole	2026-01-08
2025-09-30	$149,404	35,237	-0.8%	Shares	Sole	2025-10-29
2025-06-30	$74,947	35,520	-1.7%	Shares	Sole	2025-07-10
2025-03-31	$44,092	36,141	-29.8%	Shares	Sole	2025-04-16
2024-12-31	$66,447	51,510	+46.8%	Shares	Sole	2025-03-17
2024-09-30	$96,519	35,098	+0.5%	Shares	Sole	2024-10-24
2024-06-30	$78,896	34,910	+87.3%	Shares	Sole	2024-07-16
2024-03-31	$44,547	18,639	0.0%	Shares	Sole	2024-04-15
2023-12-31	$30,940	18,639	0.0%	Shares	Sole	2024-01-30
2023-09-30	$35,786	18,639	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.